CAMP4 Therapeutics Corporation Common Stock vs. Eli Lilly & Co.
CAMP
CAMP4 Therapeutics Corporation Common Stock
$4.48 -0.22%
VS LLYEli Lilly & Co.
$1159.60 -0.04%
Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| CAMP | LLY | |
|---|---|---|
| Market Cap | $281.76 million | $1.03 trillion |
| Revenue (TTM) | $4.22 million | $79.67 billion |
| Net Income (TTM) | $-107,244,000 | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| CAMP | LLY | |
|---|---|---|
| P/E Ratio | — | 38.93 |
| Price / Book | -406.58 | 30.51 |
| Price / Sales | 66.83 | 12.97 |
CAMP and LLY split the valuation factors evenly.
Profitability
| CAMP | LLY | |
|---|---|---|
| Net Margin | -2543.74% | 33.53% |
| Return on Equity | 15475.32% | 78.84% |
CAMP and LLY split the profitability factors evenly.
Dividend
| CAMP | LLY | |
|---|---|---|
| Dividend Yield | — | 0.60% |
| Payout Ratio | — | 23.23 |
CAMP and LLY split the dividend factors evenly.
Risk & Sentiment
| CAMP | LLY | |
|---|---|---|
| Short Interest | 2.82% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: CAMP overview, CAMP financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.